Innovative Approaches to Mosquito Control in a Changing Climate
As global temperatures rise and weather patterns shift, mosquitoes and the diseases they carry are expanding into new regions. According to the World Health Organization (WHO), factors such as climate change and increased international travel are reshaping the habitats where disease-carrying mosquitoes can thrive. The impact is striking: reported cases of dengue—a viral illness transmitted by mosquito bites—more than doubled worldwide from 6.5 million in 2023 to a record 14.6 million in 2024. WHO data highlight the urgency of developing more effective, sustainable mosquito control solutions.
Mosqitter’s Chemical-Free Mosquito Traps
Enter Mosqitter, a 30-person startup based in Pennsylvania that is reimagining mosquito control beyond traditional chemical methods. Founded in 2019 with research and development roots in Ukraine, Mosqitter launched its business operations in 2021. The company’s devices are designed specifically to attract and trap female mosquitoes—the only gender responsible for biting and disease transmission—by simulating the heat, scent, and breathing cues humans naturally emit.
Anastasiia Romanova, co-founder and CEO of Mosqitter, emphasizes that their mission is to bring sustainable, chemical-free products to a market still heavily dependent on pesticides. Their flagship device, the Mosqitter Grand, incorporates multiple attractants including heat similar to human skin temperature, human skin odor mimics, light, and carbon dioxide to emulate breathing. This multifaceted approach targets female mosquitoes at the critical moment when they seek blood meals prior to laying eggs, potentially reducing mosquito populations effectively over time.
Integrating AI for Enhanced Mosquito Surveillance
Beyond trapping mosquitoes, Mosqitter is pioneering the use of artificial intelligence (AI) to transform its traps into a real-time monitoring network. By employing computer vision and neural networks, the company’s system identifies mosquito species from images of captured insects. This process involves running images through AI models, comparing results with external datasets, and validation by entomologists, resulting in a confidence score that reflects identification accuracy.
Romanova likens this methodology to “three judges analyzing a case and producing a verdict,” underscoring the robustness and reliability of their species identification system. Additionally, Mosqitter integrates environmental data—such as weather conditions, humidity, and wind—into its models to forecast mosquito population changes and potential disease risks. This data-driven approach aims to provide earlier warnings for emerging health threats linked to mosquito-borne diseases.
Product Portfolio and Market Expansion
Mosqitter’s current product lineup includes two main devices: the Mosqitter Grand, suited for larger public spaces, and the Mosqitter Mini, designed for smaller residential areas and portable monitoring. Their upcoming Febris Monitoring System, set for launch next month, will add a sophisticated data analytics layer to track mosquito populations and assess the risk of disease spread in real time.
While Febris does not diagnose diseases directly, it identifies the presence of specific mosquito species known to carry illnesses like dengue. This information is crucial for public health agencies to anticipate and manage outbreak risks effectively, explains Romanova.
On the commercial front, Mosqitter is actively seeking B2B partnerships worldwide, focusing on distributors with strong government and retail relationships. The Febris system targets institutional customers such as governments, public health agencies, airports, municipalities, and universities that require continuous, detailed mosquito surveillance.
The company has established manufacturing and sales operations in Brazil—a country with a high dengue burden—and targets key markets including the U.S., Greece, India, Ukraine, and Nigeria. Different sales strategies are employed depending on regional contexts: in Greece, Mosqitter collaborates with an established pest-control company; in the U.S., the Mini device is sold directly to consumers via Amazon and the company’s website. Partnerships with the U.K. Health Security Agency enable deployment of Febris at major airports like Heathrow and Gatwick, addressing the risk of mosquito-borne diseases entering through international travel.
Financial Outlook and Growth Potential
Mosqitter’s pricing reflects the range of applications: the Mini retails at $199, while the professional-grade Grand system is priced at $1,999. Revenue streams come from hardware sales, complemented by recurring income from Febris’ monitoring, analytics, and data services.
Looking ahead, the company forecasts generating over $1 million in revenue in 2026. Although revenue from Febris is just beginning, contract bids suggest the data monitoring business alone could exceed $3.5 million next year. Mosqitter is currently raising a $5 million funding round in two stages aligned with key milestones for Febris development, having raised $1.9 million to date.
The Story Behind the Name
Contrary to popular belief, the name “Mosqitter” is not a combination of “mosquito” and “quitter.” Instead, as co-founder and COO Olga Diachuk explains, it blends “mosquito” and “eater,” reflecting the company’s original focus on physically capturing and reducing mosquito populations through its innovative traps.
Mosqitter’s combination of deep expertise in mosquito behavior, cutting-edge AI technology, and a commitment to sustainable, chemical-free solutions positions it as a promising leader in the fight against mosquito-borne diseases amid a changing global landscape.
